2/6
07:00 am
agio
Agios to Webcast Conference Call of Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025
Low
Report
Agios to Webcast Conference Call of Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025
1/13
07:00 am
agio
Agios Announces Key 2025 Milestones for Innovative Rare Disease Portfolio
Low
Report
Agios Announces Key 2025 Milestones for Innovative Rare Disease Portfolio
1/8
08:00 am
agio
Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer
Low
Report
Cardurion Pharmaceuticals Appoints Charlotte Newman as Chief Business Officer
1/8
07:00 am
agio
FDA Accepts Agios’ Supplemental New Drug Application for PYRUKYND® (mitapivat) in Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia
Low
Report
FDA Accepts Agios’ Supplemental New Drug Application for PYRUKYND® (mitapivat) in Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia
1/3
07:00 am
agio
Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
Low
Report
Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025
12/18
09:19 am
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
12/18
07:09 am
agio
European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios' Mitapivat in Sickle Cell Disease [Yahoo! Finance]
Medium
Report
European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios' Mitapivat in Sickle Cell Disease [Yahoo! Finance]
12/18
07:00 am
agio
European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios’ Mitapivat in Sickle Cell Disease
Medium
Report
European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios’ Mitapivat in Sickle Cell Disease
12/10
10:20 am
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target raised by analysts at Royal Bank of Canada from $55.00 to $57.00. They now have an "outperform" rating on the stock.
Medium
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target raised by analysts at Royal Bank of Canada from $55.00 to $57.00. They now have an "outperform" rating on the stock.
12/9
10:55 am
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target raised by analysts at Scotiabank from $53.00 to $75.00. They now have a "sector outperform" rating on the stock.
Medium
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target raised by analysts at Scotiabank from $53.00 to $75.00. They now have a "sector outperform" rating on the stock.
12/8
12:47 pm
agio
Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat [Yahoo! Finance]
High
Report
Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat [Yahoo! Finance]
12/8
12:40 pm
agio
Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat
High
Report
Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat
12/5
10:20 am
agio
TruePKU Initiative Provides Global PKU Community an Opportunity to Share What It's Like to Live with PKU [Yahoo! Finance]
Low
Report
TruePKU Initiative Provides Global PKU Community an Opportunity to Share What It's Like to Live with PKU [Yahoo! Finance]
12/5
06:42 am
agio
Zacks Industry Outlook Highlights ResMed, Haemonetics, Phibro and Agios [Yahoo! Finance]
Low
Report
Zacks Industry Outlook Highlights ResMed, Haemonetics, Phibro and Agios [Yahoo! Finance]
11/26
10:59 am
agio
Is Agios Pharmaceuticals (AGIO) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Low
Report
Is Agios Pharmaceuticals (AGIO) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]